Dr. Michael L. Steigner, M.D.
Radiology (Diagnostic Radiology Physician)
75 Francis St, Radiology, Brigham And Women's Hospital
Boston, MA 02115
- Medicare participating
At a glance
- Medical school
- Louisiana State University School of Medicine in New Orleans (2002)
- Years since graduation
- 24
- In the NPI registry since
- 2007
- Medicare patients seen, 2024
- 1,150
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2002Medical school: Louisiana State University School of Medicine in New Orleans
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Diagnostic Radiology Physician primary
MA license 230066
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Brigham and Women's Hospital Boston, MA
- Massachusetts General Hospital Boston, MA
- Newton-Wellesley Hospital Newton, MA
- North Shore Medical Center - Salem, MA
- Brigham and Women Faulkner Hospital Jamaica Plain, MA
Medical groups
- Massachusetts General Physicians Organization Inc (3,558 clinicians)
- Brigham and Womens Physicians Organization Inc (2,994 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 1,150
- Services billed
- 1,577
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Ct scan of blood vessels of abdomen and pelvis with contrast | 431 | 411 |
| Ct scan of blood vessels of chest with contrast | 324 | 311 |
| Ct scan of heart structure with contrast | 150 | 143 |
| Ct scan of blood vessels and grafts of heart with contrast | 105 | 105 |
| Mri scan of heart before and after contrast | 80 | 80 |
| Ct scan of chest without contrast | 77 | 77 |
| Mri scan of blood vessels of abdomen | 50 | 49 |
| Mri scan of blood vessels of leg | 44 | 21 |
| Ct scan of abdominal aorta and both leg arteries with contrast | 34 | 34 |
| Mri scan of blood vessels of chest | 34 | 34 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Payments from drug and device companies
In 2025, 1 companies reported 1 payments worth $120 in total to this clinician.
| Pfizer Inc. | $120 |
|---|
| Consulting Fee | $120 |
|---|
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Pfizer Inc. Jan 21, 2025 | Consulting Fee TALZENNA · ONCOLOGY | $120 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $80.00 in research payments for these studies, mostly to the institutions running them.
- A Study Evaluating the Safety, Pharmacokinetics (PK), and Preliminary Efficacy of ABBV-399 in Participants With Advanced Solid Tumors
AbbVie Inc. · Active, not recruiting · NCT02099058
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.